TrialCurrent clinical pharmacology2020

First-in-Human Study of the Safety, Tolerability, Pharmacokinetics and - Preliminary Dynamics of Neuroprotectant 2-Iminobiotin in Healthy Subjects.

Ewoud-Jan van Hoogdalem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.